DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 129 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -47.8% | 22,700 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $23,000 | -14.8% | 23,400 | -11.7% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | -98.3% | 26,500 | -79.2% | 0.00% | -98.9% |
| Q2 2020 | $1,585,000 | +11221.4% | 127,363 | +26.4% | 0.09% | +8600.0% |
| Q1 2020 | $14,000 | -97.5% | 100,800 | +147.1% | 0.00% | -96.7% |
| Q4 2019 | $553,000 | +177.9% | 40,800 | -3.3% | 0.03% | +87.5% |
| Q3 2019 | $199,000 | – | 42,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |